PTH and postmenopausal osteoporosis: Other studies have found that the cause of postmenopausal osteoporosis was the abnormal activation of osteoclasts, and as the osteogenic drug PTH cannot alleviate osteolysis, it was not suitable for the treatment of postmenopausal osteoporosis [33].